CirculoGene Theranostics
Birmingham, US · Founded 2015 · Delaware corporation
Founders & leadership
MV
Michael V. MullenExecutive
SR
Scott RezekExecutive
CY
Chen YehNamed on SEC filing
Board
CC
Charles ClarkBoard director
EF
Edwin FinchBoard director
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 10 rounds · 2015–2023
▶$2MraisedMar 2023 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedMar 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard BrandExecutive Officer
- Mike MullenExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2M
- Placement agents
- Arcadia Securities, LLC
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.6MraisedSep 2022 · 9 investors · Other Health CareRule 506(b)
▶$2.6MraisedSep 2022 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard BrandExecutive Officer
- Mike MullenExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.6M
- Placement agents
- Arcadia Securities, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedJan 2021 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charles A. MusialExecutive Officer
- Michael V. MullenExecutive Officer, Director
- Harold B. DunnDirector
- Daniel ColemanDirector
- Thomas A. SatterfieldDirector
- Chen-Hsiung YehExecutive Officer
- Stephen EckDirector
- Robert GarvieDirector
- Scott RezekExecutive Officer
- James E. CantrellDirector
- Offering amount
- $15M
- Amount sold
- $250K
- Finders' fees
- $17.5K
- Placement agents
- Arcadia Securities, LLC
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$330KraisedSep 2019 · 6 investors · Other Health CareRule 506(b)
▶$330KraisedSep 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael V MullenExecutive Officer, Director
- Edwin FinchDirector
- Charles ClarkDirector
- Chen YehExecutive Officer
- Scott RezekExecutive Officer
- Stephen EckDirector
- Daniel ColemanDirector
- Robert GarvieDirector
- Offering amount
- $2M
- Amount sold
- $330K
- First sale
- Sep 2019
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$2MraisedNov 2018 · 6 investors · Other Health CareRule 506(b)
▶$2MraisedNov 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chen YehExecutive Officer
- Charles ClarkDirector
- Robert GarvieDirector
- Michael V MullenExecutive Officer, Director
- Scott RezekExecutive Officer
- Stephen EckDirector
- Edwin FinchDirector
- Daniel ColemanDirector
- Offering amount
- $3M
- Amount sold
- $2M
- Minimum investment
- $50K
- First sale
- Nov 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedJan 2018 · 6 investors · Other Health CareRule 506(b)
▶$1MraisedJan 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott RezekExecutive Officer
- Michael V MullenExecutive Officer, Director
- Edwin W FinchDirector
- Chen YehExecutive Officer
- Charles ClarkDirector
- Offering amount
- $3M
- Amount sold
- $1M
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$350KraisedSep 2017 · 6 investors · Other Health CareRule 506(b)
▶$350KraisedSep 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chen YehExecutive Officer
- Charles ClarkDirector
- Michael V. MullenExecutive Officer, Director
- Edwin W. FinchDirector
- Scott RezekExecutive Officer
- Offering amount
- $700K
- Amount sold
- $350K
- First sale
- Sep 2017
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$355KraisedMar 2017 · 5 investors · Other Health CareRule 506(b)
▶$355KraisedMar 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edwin FinchDirector
- Chen YehExecutive Officer
- Scott RezekExecutive Officer
- Michael V. MullenExecutive Officer, Director
- Charles ClarkDirector
- Offering amount
- $800K
- Amount sold
- $355K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CirculoGene Theranostics raised?
- CirculoGene Theranostics has disclosed $10.9M raised across 10 rounds.
- Where is CirculoGene Theranostics headquartered?
- CirculoGene Theranostics is headquartered in Birmingham, US.